Novel immune cell engagers for immunotherapy; Inventors: David B Weiner, Devivasha Bordoloi. PCT/US2022/077679. 

 Bispecific natural killer engagers that target siglec-7; Inventors: David B Weiner, Devivasha Bordoloi. PCT/US2023/065217.

Bispecific T-cell engagers targeting FSHR and methods of use in cancer therapeutics; Inventors: David B Weiner, Alfredo Perales-Puchalt, Devivasha Bordoloi, Pratik Bhojnagarwala. PCT/US2022/077665. 

Antibodies against human Siglec-9 and use thereof for immunotherapy; Inventors: David B Weiner, Devivasha Bordoloi. PCT/US2023/065215.

Antibodies against human Siglec-7 and use thereof for immunotherapy; Inventors: David B Weiner, Devivasha Bordoloi. PCT/US2023/065218.

Bispecific immune cell engagers targeting HIV and methods of use thereof. Inventors: David B Weiner, Mansi Purwar, Abhijeet Kulkarni, Daniel Park, Devivasha Bordoloi, Pratik Bhojnagarwala. PCT/US2022/078863.